BillionToOne (BLLN.US) debuts on Nasdaq with an 81.57% surge on the first day, raising its market value to nearly $4.8 billion.

According to the Wisdom Financial APP, the molecular diagnostics company BillionToOne (BLLN.US) officially listed on the Nasdaq on Thursday, with the opening stock price soaring. As of the close, the stock rose by 81.57%, and the market value quickly rose to nearly $4.8 billion, becoming a bright new stock listed against the trend against the background of the government shutdown.